Greenline Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Greenline Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54M	Hold	28,711	–	–	0.46%	54
2026 Q1	$3.67M	Hold	28,711	–	–	0.39%	61
2025 Q4	$3.5M	Hold	28,711	–	–	0.4%	59
2025 Q3	$2.88M	Hold	28,711	–	–	0.35%	61
2025 Q2	$2.38M	Hold	28,711	–	–	0.32%	65
2025 Q1	$2.33M	Hold	28,711	–	–	0.34%	65
2024 Q4	$2.59M	Hold	28,711	–	–	0.36%	62
2024 Q3	$2.84M	Hold	28,711	–	–	0.41%	56
2024 Q2	$2.67M	Hold	28,711	–	–	0.41%	57
2024 Q1	$2.72M	Hold	28,711	–	–	0.43%	52
2023 Q4	$2.56M	Buy	+28,711	New	+$2.13M	0.43%	54

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Greenline Partners's XBI Position: Q2 2026 in Review

Greenline Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 28,711 shares worth $4.54M. The position accounts for 0.46% of the portfolio, ranked #54.

Greenline Partners first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Greenline Partners held 28,711 shares of State Street SPDR S&P Biotech ETF worth $4.54M as of Q2 2026.
Greenline Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.46% of Greenline Partners's portfolio in Q2 2026, its #54 holding.
Greenline Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Greenline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.